Report Content
Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Degenerative disc disease treatment industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 End-use trends
Chapter 3 Degenerative Disc Disease Treatment Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of degenerative disc disease
3.2.1.2 Increasing investment in R&D for novel drugs development
3.2.1.3 Innovations in minimally invasive surgical techniques
3.2.1.4 Increasing rate of geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of surgical interventions
3.2.2.2 Side effects of medications and post-surgery complications
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By end-use
3.4 COVID- 19 impact analysis
3.5 Technological advancements
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Application potential
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
4.6 Strategic outlook matrix
Chapter 5 Degenerative Disc Disease Treatment Market Size and Forecast, By Product Type (USD Million)
5.1 Key trends, by product type
5.2 Drugs
5.2.1 Acetaminophen
5.2.2 NSAIDs
5.2.3 Muscle Relaxants
5.2.4 Steroids
5.2.5 Drugs by Route of Administration
5.2.5.1 Oral
5.2.5.2 Injectable
5.3 Devices
5.3.1 Cervical Spine
5.3.2 Lumbar Spine
5.3.3 Spinal Fusion
5.3.4 Thoracic Spine
Chapter 6 Degenerative Disc Disease Treatment Market Size and Forecast, By End-use (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Clinics
6.4 Others
Chapter 7 Degenerative Disc Disease Treatment Market Size and Forecast, By Region (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.3.7 Sweden
7.3.8 The Netherlands
7.3.9 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Philippines
7.4.8 Malaysia
7.4.9 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Columbia
7.5.5 Chile
7.5.6 Peru
7.5.7 Rest of Latin America
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Israel
7.6.5 Turkey
7.6.6 Iran
7.6.7 Rest of MEA
Chapter 8 Company Profiles
8.1 Pfizer Inc
8.2 Medtronic plc
8.3 B. Braun Melsungen AG
8.4 Zimmer Biomet Holdings, Inc.
8.5 Novartis AG
8.6 Stryker
8.7 Ensol Biosciences Inc.
8.8 Johnson & Johnson
8.9 Paradigm Spine LLC
8.10 Globus Medical, Inc.
8.11 Spine BioPharma's
8.12 DiscGenics, Inc
